10-87952143-G-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000314.8(PTEN):c.518G>C(p.Arg173Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R173C) has been classified as Pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.518G>C | p.Arg173Pro | missense_variant | 6/9 | ENST00000371953.8 | NP_000305.3 | |
PTEN | NM_001304717.5 | c.1037G>C | p.Arg346Pro | missense_variant | 7/10 | NP_001291646.4 | ||
PTEN | NM_001304718.2 | c.-74G>C | 5_prime_UTR_variant | 6/9 | NP_001291647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTEN | ENST00000371953.8 | c.518G>C | p.Arg173Pro | missense_variant | 6/9 | 1 | NM_000314.8 | ENSP00000361021.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 09, 2019 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. A different missense substitution at this codon (p.Arg173Cys) has been determined to be pathogenic (PMID: 17526800, 25669429, 24778394, 22628360, 10866302). This suggests that the arginine residue is critical for PTEN protein function and that other missense substitutions at this position may also be pathogenic. Experimental studies have shown that this missense change abolishes PTEN phosphatase activity in vitro (PMID: 10866302). This variant has been reported in an individual affected with adult-onset Lhermitte-Duclos disease (PMID: 19719509), and an individual with Cowden syndrome (Invitae). ClinVar contains an entry for this variant (Variation ID: 185195). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with proline at codon 173 of the PTEN protein (p.Arg173Pro). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and proline. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 26, 2021 | Identified in a patient with Lhermitte-Duclos disease, macrocephaly, mild intellectual disability, multiple cutaneous findings, and mental health concerns in the published literature (Kirches et al., 2010); Published functional studies demonstrate a damaging effect: absent phosphatase activity (Han 2000, Mighell 2018); Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25669429, 32506314, 24778394, 22628360, 17526800, 15492994, 10866302, 28152038, 29706350, 11875759, 19719509) - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2014 | The p.R173P variant (also known as c.518G>C), located in coding exon 6 of the PTEN gene, results from a G to C substitution at nucleotide position 518. The arginine at codon 173 is replaced by proline, an amino acid with dissimilar properties. This variant has been identified in one individual with Lhermitte-Duclos disease who also fulfills clinical criteria for Cowden syndrome (Kirches E, Neuropathol. Appl. Neurobiol. 2010 Feb; 36(1):86-9). In one functional study, this variant was observed to have reduced phosphatase activity in an in vitro e. coli expression assay (Han SY et al. Cancer Res. 2000 Jun; 60(12):3147-51). This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.001% (greater than 83000 alleles tested) in our clinical cohort. This amino acid position is completely conserved on sequence alignment. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at